Get started
Author

Mara Negri

A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG)
2015 · Simona Sammassimo, Giancarlo Pruneri, et al. · Hematological Oncology · 68
A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy
2010 · Simona Bassi, Cristina Rabascio, et al. · Transfusion and Apheresis Science · 34
Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine as Therapy in Untreated and Relapsed Waldenström's Macroglobulinemia
2011 · D Laszlo, G Andreola, et al. · Clinical Lymphoma Myeloma & Leukemia · 20
Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial
2021 · Silvia Dellapasqua, Pamela Trillo Aliaga, et al. · Current Oncology · 15
PDF
Chlorambucil–rituximab as first‐line therapy in patients affected by follicular non‐Hodgkin's lymphoma: a retrospective single‐centre study
2014 · Giovanni Martinelli, Juan Montoro, et al. · Hematological Oncology · 13
Who should be really considered as a poor mobilizer in the plerixafor era?
2012 · Giovanna Andreola, Anna Vanazzi, et al. · Transfusion and Apheresis Science · 11
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients
2010 · Paola Bertazzoni, Cristina Rabascio, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients
2023 · Elisabetta Munzone, Alessandra Fabi, et al. · Drugs & Therapy Perspectives · 5
PDF
Interim 18f[FDG] Positron Emission Tomography in Patients with Diffuse Large B-Cell Lymphoma
2008 · Federica Gigli, Luca Nassi, et al. · Blood · 5
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas
2020 · Barbara Vannata, Anna Vanazzi, et al. · Hematological Oncology · 4
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma
2014 · Juan Montoro, Giovanna Andreola, et al. · Transfusion and Apheresis Science · 3
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia and Second Malignancy Following Yttrium-90 Ibritumomab Tiuxetan: 10-Year Single-Institution Experience of 138 Consecutive Patients
2012 · Anna Vanazzi, Chiara Grana, et al. · Blood · 3
Potential Pathogenetic Role of Achromobacter (Alcaligenes) Xylosoxidans in Primary Extranodal Marginal Zone Lymphoma of the Lung (BALT-Lymphoma): Update of the Results of a Retrospective Analysis on Behalf of IELSG
2011 · Simona Sammassimo, Giancarlo Pruneri, et al. · Blood · 3
Effect of a Multimedia-Assisted Informed Consent Procedure on the Information Gain of Patients Undergoing Mastectomy and Implant-Based Reconstruction
2025 · Francesca De Lorenzi, Riccardo Carbonaro, et al. · Aesthetic Plastic Surgery · 2
PDF
ecancermedicalscience
2016 · E Cocorocchio, A Vanazzi, et al. · ecancermedicalscience · 2
PDF
Prognostic role of interim 18FDG-PET in Hodgkin lymphoma: A single-center experience
2009 · E. Cocorocchio, A. Vanazzi, et al. · Journal of Clinical Oncology · 2
Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugs
2026 · R Dell’Acqua, M H Parrinello, et al. · JAC-Antimicrobial Resistance · 1
The More Effective and the More (bio) Similar: Plerixafor and Filgrastim XM02 (tevagastrim) As First Line PBSC Mobilization Strategy in Patients with Multiple Myeloma and Lymphomas Candidate to ABMT
2011 · Daniele Laszlo, Giovanna Andreola, et al. · Blood · 1
Author response for "A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas"
2020 · Barbara Vannata, Anna Vanazzi, et al.
Abstract P2-14-18: Caelyx® as adjuvant treatment in early stage luminal B breast cancer: A feasibility phase II trial
2020 · Silvia Dellapasqua, Vincenzo Bagnardi, et al. · Cancer Research
Unmanipulated, G-CSF Mobilized Peripheral Blood Stem Cells As Graft Source for Non-Myeloablative Haploidentical Transplantation: Fast Engraftment, No Evidence of Graft Rejection, and Low Incidence of Graft-Versus-Host Disease
2015 · Rocco Pastano, Giovanna Andreola, et al. · Blood
Non-Myeloablative Haploidentical Transplantation of Unmanipulated, G-CSF Mobilized Peripheral Blood Stem Cells with High Dose Post-Transplant Cyclophosphamide: Fast Engraftment, No Evidence of Graft Rejection and Low Incidence of Graft-Versus-Host-Disease
2014 · Rocco Pastano, Giovanna Andreola, et al. · Blood
Efficacy of 90yttrium-Ibritumomab Tiuxetan in Extranodal Marginal-Zone Lymphoma,
2011 · Anna Vanazzi, Chiara Grana, et al. · Blood
Rituximab Plus Chlorambucil Compared with Chlorambucil and Prednisone In Patients with Untreated Follicular Lymphoma
2010 · Simona Bassi, Simona Sammassimo, et al. · Blood
PRIMARY EXTRANODAL MARGINAL ZONE LYMPHOMA of the LUNG (BALT-LYMPHOMA): Results of a Retrospective Analysis on Behalf of IELSG
2010 · Simona Sammassimo, Giancarlo Pruneri, et al. · Blood
Works count: 27
Citation count: 203
H-index: 7
I10-index: 7
Year
Topic
Type